COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,397 Articles (22,816 medRxiv, 8,581 bioRxiv)

Most recent first Previous |  Page 1322: Articles 13211-13220  | Next

Structural Differences In 3C-like protease (Mpro) From SARS-CoV and SARS-CoV-2: Molecular Insights For Drug Repurposing Against COVID-19 Revealed by Molecular Dynamics Simulations.
Patel, D., Parmar, M., Thumar, R., Patel, B., Athar, M., Jha, P.
10.1101/2021.08.11.455903 — Posted: 2021-08-11
Molecular mimicry between Spike and human thrombopoietin may induce thrombocytopenia in COVID-19
Nunez-Castilla, J., Stebliankin, V., Baral, P., Balbin, C. A., Sobhan, M., Cickovski, T., Mondal, A. M., Narasimhan, G., Chapagain, P., Mathee, K., Siltberg-Liberles, J.
10.1101/2021.08.10.455737 — Posted: 2021-08-11
Multiplexed detection of SARS-CoV-2 genomic and subgenomic RNA using in situ hybridization
Acheampong, K. K., Schaff, D. L., Emert, B. L., Lake, J., Reffsin, S., Shea, E. K., Comar, C. E., Litzky, L. A., Khurram, N. A., Linn, R. L., Feldman, M., Weiss, S. R., Montone, K. T., Cherry, S., Shaffer, S. M.
10.1101/2021.08.11.455959 — Posted: 2021-08-11 Discussion: Onsite
N-dihydrogalactochitosan reduces mortality in a lethal mouse model of SARS-CoV-2
Weiss, C. M., Liu, H., Ball, E. E., Lam, S., Hode, T., Keel, M. K., Levenson, R. M., Coffey, L. L.
10.1101/2021.08.10.455872 — Posted: 2021-08-11
SARS-CoV-2 Spike Affinity and Dynamics Exclude the Strict Requirement of an Intermediate Host
Castelli, M., Scietti, L., Clementi, N., Cavallaro, M., Faravelli, S., Pinnola, A., Criscuolo, E., Diotti, R. A., Clementi, M., Forneris, F., Mancini, N.
10.1101/2021.08.11.455960 — Posted: 2021-08-11
Molecular basis of immune evasion by the delta and kappa SARS-CoV-2 variants
McCallum, M., Walls, A. C., Sprouse, K. R., Bowen, J. E., Rosen, L., Dang, H. V., deMarco, A., Franko, N., Tilles, S. W., Logue, J., Miranda, M. C., Ahlrichs, M., Carter, L., Snell, G., Pizzuto, M. S., Chu, H. Y., Van Voorhis, W. C., Corti, D., Veesler, D.
10.1101/2021.08.11.455956 — Posted: 2021-08-11
A single shot of a hybrid hAdV5-based anti-COVID-19 vaccine induces a long-lasting immune response and broad coverage against VOC
Lopez, M. V., Vinzon, S. E., Cafferata, E. G. A., Nunez, F. J., Soto, A., Sanchez-Lamas, M., Afonso, J., Aguilar-Cortes, D., Rios, G. D., Maricato, J. T., Torres-Braconi, C., Barbosa-da Silveira, V., Montes-de Andrade, T., Carvalho-de Souza Bonetti, T., Ramos Janini, L. M., Castello Girao, M. J. B., Llera, A. S., Gomez, K., Hortega, H. H., Berguer, P. M., Podhajcer, O. L.
10.1101/2021.08.11.455942 — Posted: 2021-08-11
CytokineLink: a cytokine communication map to analyse immune responses in inflammatory and infectious diseases
Olbei, M. L., Thomas, J., Hautefort, I., Treveil, A., Bohar, B., Madgwick, M., Potari-Gul, L., Csabai, L., Modos, D., Korcsmaros, T.
10.1101/2021.08.10.455874 — Posted: 2021-08-11
BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the Delta (B.1.617.2) variant in Qatar
Tang, P., Hasan, M. R., Chemaitelly, H., YASSINE, H. M., Benslimane, F., Al Khatib, H. A., AlMukdad, S., Coyle, P., Ayoub, H. H., Al Kanaani, Z., Al Kuwari, E., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul Rahim, H. F., Nasrallah, G., Al Kuwari, M. G., Al Romaihi, H. E., Butt, A. A., Al-Thani, M. H., Al Khal, A., Bertollini, R., Abu-Raddad, L. J.
10.1101/2021.08.11.21261885 — Posted: 2021-08-11 Discussion: Onsite
Mental health impacts of the COVID-19 pandemic on children and adolescents with chronic health conditions
Crowe, L., Clarke, C., Hearps, S., Pugh, R., Kilpatrick, N., Branson, E., Payne, J., Haebich, K., McCloughan, N., Kintakas, C., Charles, G., Trajanovska, M., Hsieh, I., Hartmann, P., King, S., Anderson, N., Anderson, V.
10.1101/2021.08.10.21261816 — Posted: 2021-08-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).